WHO Classification of Tumours Editorial Board (2019) Breast tumours. WHO classification of tumors series, vol 2, 5th edn. International Agency for Research on Cancer, Lyon
Lyons TG (2019) Targeted therapies for triple-negative breast cancer. Curr Treat Options Oncol 20(11):82. https://doi.org/10.1007/s11864-019-0682-x
Zhao S, Ma D, Xiao Y, Li XM, Ma JL, Zhang H et al (2020) Molecular subtyping of triple-negative breast cancers by immunohistochemistry: molecular basis and clinical relevance. Oncologist 25(10):e1481–e1491. https://doi.org/10.1634/theoncologist.2019-0982
Article CAS PubMed PubMed Central Google Scholar
Curigliano G, Burstein HJ, Winer EP, Gnant M, Dubsky P, Loibl S et al (2018) De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International expert consensus conference on the primary therapy of early breast cancer 2017. Ann Oncol 28(8):1700–1712. https://doi.org/10.1093/annonc/mdx308
Wenzel ES, Singh ATK (2018) Cell-cycle checkpoints and aneuploidy on the path to cancer. In Vivo 32(1):1–5. https://doi.org/10.21873/invivo.11197
Article CAS PubMed PubMed Central Google Scholar
Loibl S, Poortmans P, Morrow M, Denkert C, Curigliano G (2021) Breast cancer. Lancet 397(10286):1750–1769. https://doi.org/10.1016/S0140-6736(20)32381-3
Article CAS PubMed Google Scholar
Arafah MA, Ouban A, Ameer OZ, Quek KJ (2021) Ki-67 LI expression in triple-negative breast cancer patients and its significance. Breast Cancer (Auckl) 15:11782234211016976. https://doi.org/10.1177/11782234211016977
Keam B, Im SA, Lee KH, Han SW, Oh DY, Kim JH et al (2011) Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis. Breast Cancer Res 13(2):R22. https://doi.org/10.1186/bcr2834
Article PubMed PubMed Central Google Scholar
Wang RX, Chen S, Jin X, Shao ZM (2016) Value of Ki-67 expression in triple-negative breast cancer before and after neoadjuvant chemotherapy with weekly paclitaxel plus carboplatin. Sci Rep 6:30091. https://doi.org/10.1038/srep30091
Article CAS PubMed PubMed Central Google Scholar
Nishimura R, Osako T, Okumura Y, Hayashi M, Arima N (2010) Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis. Breast Cancer 17:269–275. https://doi.org/10.1007/s12282-009-0161-5
Zhu X, Chen L, Huang B, Wang Y, Ji L, Wu J et al (2020) The prognostic and predictive potential of Ki-67 in triple-negative breast cancer. Sci Rep 10(1):225. https://doi.org/10.1038/s41598-019-57094-3
Article CAS PubMed PubMed Central Google Scholar
Miyashita M, Ishida T, Ishida K, Tamaki K, Amari M, Watanabe M et al (2011) Histopathological subclassification of triple negative breast cancer using prognostic scoring system: five variables as candidates. Virchows Arch 458(1):65–72. https://doi.org/10.1007/s00428-010-1009-2
Munzone E, Botteri E, Sciandivasci A, Curigliano G, Nolè F, Mastropasqua M et al (2012) Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancer. Breast Cancer Res Treat 134(1):277–282. https://doi.org/10.1007/s10549-012-2040-6
Røge R, Nielsen S, Riber-Hansen R, Vyberg M (2021) Ki-67 proliferation index in breast cancer as a function of assessment method: a NordiQC experience. Appl Immunohistochem Mol Morphol 29(2):99–104. https://doi.org/10.1097/PAI.0000000000000846
Article CAS PubMed Google Scholar
Sun X, Kaufman PD (2018) Ki-67: more than a proliferation marker. Chromosoma 127(2):175–186. https://doi.org/10.1007/s00412-018-0659-8
Article CAS PubMed PubMed Central Google Scholar
Matthews HK, Bertoli C, de Bruin RAM (2022) Cell cycle control in cancer. Nat Rev Mol Cell Biol 23(1):74–88. https://doi.org/10.1038/s41580-021-00404-3
Article CAS PubMed Google Scholar
Risteski P, Jagrić M, Pavin N, Tolić IM (2021) Biomechanics of chromosome alignment at the spindle midplane. Curr Biol 31(10):R574–R585. https://doi.org/10.1016/j.cub.2021.03.082
Article CAS PubMed Google Scholar
Potapova T, Gorbsky GJ (2017) The consequences of chromosome segregation errors in mitosis and meiosis. Biology (Basel) 6(1):12. https://doi.org/10.3390/biology6010012
Burstein HJ, Curigliano G, Thürlimann B, Weber WP, Poortmans P, Regan MM et al (2021) Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International consensus guidelines for treatment of early breast cancer 2021. Ann Oncol 32(10):1216–1235. https://doi.org/10.1016/j.annonc.2021.06.023
Article CAS PubMed Google Scholar
Goldhirsch A, Ingle JN, Gelber RD, Coates AS, Thürlimann B, Senn HJ (2009) Thresholds for therapies: highlights of the St Gallen International expert consensus on the primary therapy of early breast cancer. Ann Oncol 20:1319–1329. https://doi.org/10.1093/annonc/mdp322
Article CAS PubMed PubMed Central Google Scholar
Botti G, Cantile M, Collina F, Cerrone M, Sarno S, Anniciello A (2019) Morphological and pathological features of basal-like breast cancer. Transl Cancer Res 8(Suppl 5):S503–S509. https://doi.org/10.21037/tcr.2019.06.50
Article CAS PubMed PubMed Central Google Scholar
Repo H, Löyttyniemi E, Nykänen M, Lintunen M, Karra H, Pitkänen R et al (2016) The expression of cohesin subunit SA2 predicts breast cancer survival. Appl Immunohistochem Mol Morphol 24(9):615–621. https://doi.org/10.1097/PAI.0000000000000240
Article CAS PubMed Google Scholar
Tuominen VJ, Ruotoistenmäki S, Viitanen A, Jumppanen M, Isola J (2010) ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67. Breast Cancer Res 12(4):R56. https://doi.org/10.1186/bcr2615
Article PubMed PubMed Central Google Scholar
Therneau T (2022) A package for survival analysis in R. R package version 3.3–1. https://CRAN.R-project.org/package=survival.
Kassambara A, Kosinski M, Biece P, Scheipl F (2021) Drawing survival curves using 'ggplot2'. R package version 0.4.9. https://mran.revolutionanalytics.com/package/survminer
Dai D, Zhong Y, Wang Z, Yousafzai NA, Jin H, Wang X et al (2019) The prognostic impact of age in different molecular subtypes of breast cancer: a population-based study. PeerJ 7:e7252. https://doi.org/10.7717/peerj.7252
Article PubMed PubMed Central Google Scholar
Johansson ALV, Trewin CB, Hjerkind KV, Ellingjord-Dale M, Johannesen TB, Ursin G et al (2019) Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort. Int J Cancer 144(6):1251–1261. https://doi.org/10.1002/ijc.31950
Article CAS PubMed Google Scholar
Chen HL, Zhou MQ, Tian W, Meng KX, He HF (2016) Effect of age on breast cancer patient prognoses: a population-based study using the SEER 18 database. PLoS ONE 11(10):e0165409. https://doi.org/10.1371/journal.pone.0165409
Article CAS PubMed PubMed Central Google Scholar
Alabdulkareem H, Pinchinat T, Khan S, Landers A, Christos P, Simmons R et al (2018) The impact of molecular subtype on breast cancer recurrence in young women treated with contemporary adjuvant therapy. Breast J 24(2):148–153. https://doi.org/10.1111/tbj.12853
Article CAS PubMed Google Scholar
Chung WP, Lee KT, Chen YP, Hsu YT, Loh ZJ, Huang CC et al (2021) The prognosis of early-stage breast cancer in extremely young female patients. Medicine (Baltimore) 100(1):e24076. https://doi.org/10.1097/MD.0000000000024076
Liu Y, Xin T, Huang DY, Shen WX, Li L, Lv YJ et al (2014) Prognosis in very young women with triple-negative breast cancer: retrospective study of 216 cases. Med Oncol 31(12):222. https://doi.org/10.1007/s12032-014-0222-2
Aine M, Boyaci C, Hartman J, Häkkinen J, Mitra S, Campos AB et al (2021) Molecular analyses of triple-negative breast cancer in the young and elderly. Breast Cancer Res 23(1):20. https://doi.org/10.1186/s13058-021-01392-0
Article CAS PubMed PubMed Central Google Scholar
Lian W, Fu F, Lin Y, Lu M, Chen B, Yang P et al (2017) The impact of young age for prognosis by subtype in women with early breast cancer. Sci Rep 7(1):11625. https://doi.org/10.1038/s41598-017-10414-x
Article CAS PubMed PubMed Central Google Scholar
Fallahpour S, Navaneelan T, De P, Borgo A (2017) Breast cancer survival by molecular subtype: a population-based analysis of cancer registry data. CMAJ Open 5(3):E734–E739. https://doi.org/10.9778/cmajo.20170030
Article PubMed PubMed Central Google Scholar
Fredholm H, Magnusson K, Lindström LS, Garmo H, Fält SE, Lindman H et al (2016) Long-term outcome in young women with breast cancer: a population-based study. Breast Cancer Res Treat 160(1):131–143. https://doi.org/10.1007/s10549-016-3983-9
Article PubMed PubMed Central Google Scholar
Chollet-Hinton L, Anders CK, Tse CK, Bell MB, Yang YC, Carey LA et al (2016) Breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the Carolina breast cancer study: a case-control study. Breast Cancer Res 18(1):79. https://doi.org/10.1186/s13058-016-0736-y
Article PubMed PubMed Central Google Scholar
Tzikas AK, Nemes S, Linderholm BK (2020) A comparison between young and old patients with triple-negative breast cancer: biology, survival and metastatic patterns. Breast Cancer Res Treat 182(3):643–654. https://doi.org/10.1007/s10549-020-05727-x
留言 (0)